Brief: Relay Therapeutics Reports First Quarter 2023 Financial Results And Corporate Highlights
Relay Therapeutics Inc RLAY.O :
* RELAY THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND CORPORATE HIGHLIGHTS
* $937.8 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS
AT END
OF Q1 2023, EXPECTED TO FUND OPERATIONS INTO 2025
* QTRLY NET LOSS PER SHARE OF $0.78
* Q1 EARNINGS PER SHARE VIEW $-0.69 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6k3QQn
Further company coverage: RLAY.O
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers